Global GLP-1 Agonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global GLP-1 Agonist market size was valued at USD 21200 million in 2022 and is forecast to a readjusted size of USD 59500 million by 2029 with a CAGR of 15.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.
This report is a detailed and comprehensive analysis for global GLP-1 Agonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global GLP-1 Agonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 Agonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 Agonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 Agonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Agonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Agonist market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Sanofi, GSK and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
GLP-1 Agonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe GLP-1 Agonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 Agonist, with price, sales, revenue and global market share of GLP-1 Agonist from 2018 to 2023.
Chapter 3, the GLP-1 Agonist competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 Agonist breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and GLP-1 Agonist market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Agonist.
Chapter 14 and 15, to describe GLP-1 Agonist sales channel, distributors, customers, research findings and conclusion.
GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.
This report is a detailed and comprehensive analysis for global GLP-1 Agonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global GLP-1 Agonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 Agonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 Agonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1 Agonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Agonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Agonist market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Sanofi, GSK and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
GLP-1 Agonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Long-Acting Drug
- Short-Acting Drug
- Diabetes
- Obesity
- Nonalcoholic Fatty Liver Disease
- Metabolic Disorder
- Alzheimer's Disease
- Other
- Novo Nordisk
- AstraZeneca
- Sanofi
- GSK
- Eli Lilly
- Zealand Pharma A/S
- hansoh
- BENEMAE
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe GLP-1 Agonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 Agonist, with price, sales, revenue and global market share of GLP-1 Agonist from 2018 to 2023.
Chapter 3, the GLP-1 Agonist competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 Agonist breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and GLP-1 Agonist market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Agonist.
Chapter 14 and 15, to describe GLP-1 Agonist sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of GLP-1 Agonist
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1 Agonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Long-Acting Drug
1.3.3 Short-Acting Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1 Agonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diabetes
1.4.3 Obesity
1.4.4 Nonalcoholic Fatty Liver Disease
1.4.5 Metabolic Disorder
1.4.6 Alzheimer's Disease
1.4.7 Other
1.5 Global GLP-1 Agonist Market Size & Forecast
1.5.1 Global GLP-1 Agonist Consumption Value (2018 & 2022 & 2029)
1.5.2 Global GLP-1 Agonist Sales Quantity (2018-2029)
1.5.3 Global GLP-1 Agonist Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1 Agonist Product and Services
2.1.4 Novo Nordisk GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca GLP-1 Agonist Product and Services
2.2.4 AstraZeneca GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi GLP-1 Agonist Product and Services
2.3.4 Sanofi GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK GLP-1 Agonist Product and Services
2.4.4 GSK GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly GLP-1 Agonist Product and Services
2.5.4 Eli Lilly GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly Recent Developments/Updates
2.6 Zealand Pharma A/S
2.6.1 Zealand Pharma A/S Details
2.6.2 Zealand Pharma A/S Major Business
2.6.3 Zealand Pharma A/S GLP-1 Agonist Product and Services
2.6.4 Zealand Pharma A/S GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zealand Pharma A/S Recent Developments/Updates
2.7 hansoh
2.7.1 hansoh Details
2.7.2 hansoh Major Business
2.7.3 hansoh GLP-1 Agonist Product and Services
2.7.4 hansoh GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 hansoh Recent Developments/Updates
2.8 BENEMAE
2.8.1 BENEMAE Details
2.8.2 BENEMAE Major Business
2.8.3 BENEMAE GLP-1 Agonist Product and Services
2.8.4 BENEMAE GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BENEMAE Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLP-1 AGONIST BY MANUFACTURER
3.1 Global GLP-1 Agonist Sales Quantity by Manufacturer (2018-2023)
3.2 Global GLP-1 Agonist Revenue by Manufacturer (2018-2023)
3.3 Global GLP-1 Agonist Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of GLP-1 Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 GLP-1 Agonist Manufacturer Market Share in 2022
3.4.2 Top 6 GLP-1 Agonist Manufacturer Market Share in 2022
3.5 GLP-1 Agonist Market: Overall Company Footprint Analysis
3.5.1 GLP-1 Agonist Market: Region Footprint
3.5.2 GLP-1 Agonist Market: Company Product Type Footprint
3.5.3 GLP-1 Agonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global GLP-1 Agonist Market Size by Region
4.1.1 Global GLP-1 Agonist Sales Quantity by Region (2018-2029)
4.1.2 Global GLP-1 Agonist Consumption Value by Region (2018-2029)
4.1.3 Global GLP-1 Agonist Average Price by Region (2018-2029)
4.2 North America GLP-1 Agonist Consumption Value (2018-2029)
4.3 Europe GLP-1 Agonist Consumption Value (2018-2029)
4.4 Asia-Pacific GLP-1 Agonist Consumption Value (2018-2029)
4.5 South America GLP-1 Agonist Consumption Value (2018-2029)
4.6 Middle East and Africa GLP-1 Agonist Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global GLP-1 Agonist Sales Quantity by Type (2018-2029)
5.2 Global GLP-1 Agonist Consumption Value by Type (2018-2029)
5.3 Global GLP-1 Agonist Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global GLP-1 Agonist Sales Quantity by Application (2018-2029)
6.2 Global GLP-1 Agonist Consumption Value by Application (2018-2029)
6.3 Global GLP-1 Agonist Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America GLP-1 Agonist Sales Quantity by Type (2018-2029)
7.2 North America GLP-1 Agonist Sales Quantity by Application (2018-2029)
7.3 North America GLP-1 Agonist Market Size by Country
7.3.1 North America GLP-1 Agonist Sales Quantity by Country (2018-2029)
7.3.2 North America GLP-1 Agonist Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe GLP-1 Agonist Sales Quantity by Type (2018-2029)
8.2 Europe GLP-1 Agonist Sales Quantity by Application (2018-2029)
8.3 Europe GLP-1 Agonist Market Size by Country
8.3.1 Europe GLP-1 Agonist Sales Quantity by Country (2018-2029)
8.3.2 Europe GLP-1 Agonist Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific GLP-1 Agonist Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific GLP-1 Agonist Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific GLP-1 Agonist Market Size by Region
9.3.1 Asia-Pacific GLP-1 Agonist Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific GLP-1 Agonist Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America GLP-1 Agonist Sales Quantity by Type (2018-2029)
10.2 South America GLP-1 Agonist Sales Quantity by Application (2018-2029)
10.3 South America GLP-1 Agonist Market Size by Country
10.3.1 South America GLP-1 Agonist Sales Quantity by Country (2018-2029)
10.3.2 South America GLP-1 Agonist Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa GLP-1 Agonist Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa GLP-1 Agonist Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa GLP-1 Agonist Market Size by Country
11.3.1 Middle East & Africa GLP-1 Agonist Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa GLP-1 Agonist Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 GLP-1 Agonist Market Drivers
12.2 GLP-1 Agonist Market Restraints
12.3 GLP-1 Agonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of GLP-1 Agonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Agonist
13.3 GLP-1 Agonist Production Process
13.4 GLP-1 Agonist Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1 Agonist Typical Distributors
14.3 GLP-1 Agonist Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of GLP-1 Agonist
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1 Agonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Long-Acting Drug
1.3.3 Short-Acting Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1 Agonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diabetes
1.4.3 Obesity
1.4.4 Nonalcoholic Fatty Liver Disease
1.4.5 Metabolic Disorder
1.4.6 Alzheimer's Disease
1.4.7 Other
1.5 Global GLP-1 Agonist Market Size & Forecast
1.5.1 Global GLP-1 Agonist Consumption Value (2018 & 2022 & 2029)
1.5.2 Global GLP-1 Agonist Sales Quantity (2018-2029)
1.5.3 Global GLP-1 Agonist Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1 Agonist Product and Services
2.1.4 Novo Nordisk GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca GLP-1 Agonist Product and Services
2.2.4 AstraZeneca GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi GLP-1 Agonist Product and Services
2.3.4 Sanofi GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK GLP-1 Agonist Product and Services
2.4.4 GSK GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly GLP-1 Agonist Product and Services
2.5.4 Eli Lilly GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly Recent Developments/Updates
2.6 Zealand Pharma A/S
2.6.1 Zealand Pharma A/S Details
2.6.2 Zealand Pharma A/S Major Business
2.6.3 Zealand Pharma A/S GLP-1 Agonist Product and Services
2.6.4 Zealand Pharma A/S GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zealand Pharma A/S Recent Developments/Updates
2.7 hansoh
2.7.1 hansoh Details
2.7.2 hansoh Major Business
2.7.3 hansoh GLP-1 Agonist Product and Services
2.7.4 hansoh GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 hansoh Recent Developments/Updates
2.8 BENEMAE
2.8.1 BENEMAE Details
2.8.2 BENEMAE Major Business
2.8.3 BENEMAE GLP-1 Agonist Product and Services
2.8.4 BENEMAE GLP-1 Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BENEMAE Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLP-1 AGONIST BY MANUFACTURER
3.1 Global GLP-1 Agonist Sales Quantity by Manufacturer (2018-2023)
3.2 Global GLP-1 Agonist Revenue by Manufacturer (2018-2023)
3.3 Global GLP-1 Agonist Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of GLP-1 Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 GLP-1 Agonist Manufacturer Market Share in 2022
3.4.2 Top 6 GLP-1 Agonist Manufacturer Market Share in 2022
3.5 GLP-1 Agonist Market: Overall Company Footprint Analysis
3.5.1 GLP-1 Agonist Market: Region Footprint
3.5.2 GLP-1 Agonist Market: Company Product Type Footprint
3.5.3 GLP-1 Agonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global GLP-1 Agonist Market Size by Region
4.1.1 Global GLP-1 Agonist Sales Quantity by Region (2018-2029)
4.1.2 Global GLP-1 Agonist Consumption Value by Region (2018-2029)
4.1.3 Global GLP-1 Agonist Average Price by Region (2018-2029)
4.2 North America GLP-1 Agonist Consumption Value (2018-2029)
4.3 Europe GLP-1 Agonist Consumption Value (2018-2029)
4.4 Asia-Pacific GLP-1 Agonist Consumption Value (2018-2029)
4.5 South America GLP-1 Agonist Consumption Value (2018-2029)
4.6 Middle East and Africa GLP-1 Agonist Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global GLP-1 Agonist Sales Quantity by Type (2018-2029)
5.2 Global GLP-1 Agonist Consumption Value by Type (2018-2029)
5.3 Global GLP-1 Agonist Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global GLP-1 Agonist Sales Quantity by Application (2018-2029)
6.2 Global GLP-1 Agonist Consumption Value by Application (2018-2029)
6.3 Global GLP-1 Agonist Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America GLP-1 Agonist Sales Quantity by Type (2018-2029)
7.2 North America GLP-1 Agonist Sales Quantity by Application (2018-2029)
7.3 North America GLP-1 Agonist Market Size by Country
7.3.1 North America GLP-1 Agonist Sales Quantity by Country (2018-2029)
7.3.2 North America GLP-1 Agonist Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe GLP-1 Agonist Sales Quantity by Type (2018-2029)
8.2 Europe GLP-1 Agonist Sales Quantity by Application (2018-2029)
8.3 Europe GLP-1 Agonist Market Size by Country
8.3.1 Europe GLP-1 Agonist Sales Quantity by Country (2018-2029)
8.3.2 Europe GLP-1 Agonist Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific GLP-1 Agonist Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific GLP-1 Agonist Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific GLP-1 Agonist Market Size by Region
9.3.1 Asia-Pacific GLP-1 Agonist Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific GLP-1 Agonist Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America GLP-1 Agonist Sales Quantity by Type (2018-2029)
10.2 South America GLP-1 Agonist Sales Quantity by Application (2018-2029)
10.3 South America GLP-1 Agonist Market Size by Country
10.3.1 South America GLP-1 Agonist Sales Quantity by Country (2018-2029)
10.3.2 South America GLP-1 Agonist Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa GLP-1 Agonist Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa GLP-1 Agonist Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa GLP-1 Agonist Market Size by Country
11.3.1 Middle East & Africa GLP-1 Agonist Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa GLP-1 Agonist Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 GLP-1 Agonist Market Drivers
12.2 GLP-1 Agonist Market Restraints
12.3 GLP-1 Agonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of GLP-1 Agonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Agonist
13.3 GLP-1 Agonist Production Process
13.4 GLP-1 Agonist Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1 Agonist Typical Distributors
14.3 GLP-1 Agonist Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global GLP-1 Agonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global GLP-1 Agonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1 Agonist Product and Services
Table 6. Novo Nordisk GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca GLP-1 Agonist Product and Services
Table 11. AstraZeneca GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi GLP-1 Agonist Product and Services
Table 16. Sanofi GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK GLP-1 Agonist Product and Services
Table 21. GSK GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly GLP-1 Agonist Product and Services
Table 26. Eli Lilly GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly Recent Developments/Updates
Table 28. Zealand Pharma A/S Basic Information, Manufacturing Base and Competitors
Table 29. Zealand Pharma A/S Major Business
Table 30. Zealand Pharma A/S GLP-1 Agonist Product and Services
Table 31. Zealand Pharma A/S GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Zealand Pharma A/S Recent Developments/Updates
Table 33. hansoh Basic Information, Manufacturing Base and Competitors
Table 34. hansoh Major Business
Table 35. hansoh GLP-1 Agonist Product and Services
Table 36. hansoh GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. hansoh Recent Developments/Updates
Table 38. BENEMAE Basic Information, Manufacturing Base and Competitors
Table 39. BENEMAE Major Business
Table 40. BENEMAE GLP-1 Agonist Product and Services
Table 41. BENEMAE GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BENEMAE Recent Developments/Updates
Table 43. Global GLP-1 Agonist Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global GLP-1 Agonist Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global GLP-1 Agonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in GLP-1 Agonist, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and GLP-1 Agonist Production Site of Key Manufacturer
Table 48. GLP-1 Agonist Market: Company Product Type Footprint
Table 49. GLP-1 Agonist Market: Company Product Application Footprint
Table 50. GLP-1 Agonist New Market Entrants and Barriers to Market Entry
Table 51. GLP-1 Agonist Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global GLP-1 Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global GLP-1 Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global GLP-1 Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global GLP-1 Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global GLP-1 Agonist Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global GLP-1 Agonist Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global GLP-1 Agonist Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global GLP-1 Agonist Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global GLP-1 Agonist Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global GLP-1 Agonist Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global GLP-1 Agonist Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global GLP-1 Agonist Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global GLP-1 Agonist Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global GLP-1 Agonist Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America GLP-1 Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America GLP-1 Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America GLP-1 Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America GLP-1 Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe GLP-1 Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe GLP-1 Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe GLP-1 Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe GLP-1 Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific GLP-1 Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific GLP-1 Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific GLP-1 Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific GLP-1 Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America GLP-1 Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America GLP-1 Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America GLP-1 Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America GLP-1 Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa GLP-1 Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa GLP-1 Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa GLP-1 Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa GLP-1 Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 110. GLP-1 Agonist Raw Material
Table 111. Key Manufacturers of GLP-1 Agonist Raw Materials
Table 112. GLP-1 Agonist Typical Distributors
Table 113. GLP-1 Agonist Typical Customers
List of Figures
Figure 1. GLP-1 Agonist Picture
Figure 2. Global GLP-1 Agonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global GLP-1 Agonist Consumption Value Market Share by Type in 2022
Figure 4. Long-Acting Drug Examples
Figure 5. Short-Acting Drug Examples
Figure 6. Global GLP-1 Agonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global GLP-1 Agonist Consumption Value Market Share by Application in 2022
Figure 8. Diabetes Examples
Figure 9. Obesity Examples
Figure 10. Nonalcoholic Fatty Liver Disease Examples
Figure 11. Metabolic Disorder Examples
Figure 12. Alzheimer's Disease Examples
Figure 13. Other Examples
Figure 14. Global GLP-1 Agonist Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global GLP-1 Agonist Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global GLP-1 Agonist Sales Quantity (2018-2029) & (K Units)
Figure 17. Global GLP-1 Agonist Average Price (2018-2029) & (US$/Unit)
Figure 18. Global GLP-1 Agonist Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global GLP-1 Agonist Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of GLP-1 Agonist by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 GLP-1 Agonist Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 GLP-1 Agonist Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global GLP-1 Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global GLP-1 Agonist Consumption Value Market Share by Region (2018-2029)
Figure 25. North America GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 28. South America GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 30. Global GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global GLP-1 Agonist Consumption Value Market Share by Type (2018-2029)
Figure 32. Global GLP-1 Agonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global GLP-1 Agonist Consumption Value Market Share by Application (2018-2029)
Figure 35. Global GLP-1 Agonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America GLP-1 Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America GLP-1 Agonist Consumption Value Market Share by Country (2018-2029)
Figure 40. United States GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe GLP-1 Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe GLP-1 Agonist Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific GLP-1 Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific GLP-1 Agonist Consumption Value Market Share by Region (2018-2029)
Figure 56. China GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America GLP-1 Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America GLP-1 Agonist Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa GLP-1 Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa GLP-1 Agonist Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. GLP-1 Agonist Market Drivers
Figure 77. GLP-1 Agonist Market Restraints
Figure 78. GLP-1 Agonist Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of GLP-1 Agonist in 2022
Figure 81. Manufacturing Process Analysis of GLP-1 Agonist
Figure 82. GLP-1 Agonist Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Table 1. Global GLP-1 Agonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global GLP-1 Agonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1 Agonist Product and Services
Table 6. Novo Nordisk GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca GLP-1 Agonist Product and Services
Table 11. AstraZeneca GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi GLP-1 Agonist Product and Services
Table 16. Sanofi GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK GLP-1 Agonist Product and Services
Table 21. GSK GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly GLP-1 Agonist Product and Services
Table 26. Eli Lilly GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly Recent Developments/Updates
Table 28. Zealand Pharma A/S Basic Information, Manufacturing Base and Competitors
Table 29. Zealand Pharma A/S Major Business
Table 30. Zealand Pharma A/S GLP-1 Agonist Product and Services
Table 31. Zealand Pharma A/S GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Zealand Pharma A/S Recent Developments/Updates
Table 33. hansoh Basic Information, Manufacturing Base and Competitors
Table 34. hansoh Major Business
Table 35. hansoh GLP-1 Agonist Product and Services
Table 36. hansoh GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. hansoh Recent Developments/Updates
Table 38. BENEMAE Basic Information, Manufacturing Base and Competitors
Table 39. BENEMAE Major Business
Table 40. BENEMAE GLP-1 Agonist Product and Services
Table 41. BENEMAE GLP-1 Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BENEMAE Recent Developments/Updates
Table 43. Global GLP-1 Agonist Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global GLP-1 Agonist Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global GLP-1 Agonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in GLP-1 Agonist, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and GLP-1 Agonist Production Site of Key Manufacturer
Table 48. GLP-1 Agonist Market: Company Product Type Footprint
Table 49. GLP-1 Agonist Market: Company Product Application Footprint
Table 50. GLP-1 Agonist New Market Entrants and Barriers to Market Entry
Table 51. GLP-1 Agonist Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global GLP-1 Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global GLP-1 Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global GLP-1 Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global GLP-1 Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global GLP-1 Agonist Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global GLP-1 Agonist Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global GLP-1 Agonist Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global GLP-1 Agonist Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global GLP-1 Agonist Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global GLP-1 Agonist Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global GLP-1 Agonist Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global GLP-1 Agonist Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global GLP-1 Agonist Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global GLP-1 Agonist Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America GLP-1 Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America GLP-1 Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America GLP-1 Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America GLP-1 Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe GLP-1 Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe GLP-1 Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe GLP-1 Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe GLP-1 Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific GLP-1 Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific GLP-1 Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific GLP-1 Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific GLP-1 Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America GLP-1 Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America GLP-1 Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America GLP-1 Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America GLP-1 Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa GLP-1 Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa GLP-1 Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa GLP-1 Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa GLP-1 Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa GLP-1 Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa GLP-1 Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa GLP-1 Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa GLP-1 Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 110. GLP-1 Agonist Raw Material
Table 111. Key Manufacturers of GLP-1 Agonist Raw Materials
Table 112. GLP-1 Agonist Typical Distributors
Table 113. GLP-1 Agonist Typical Customers
List of Figures
Figure 1. GLP-1 Agonist Picture
Figure 2. Global GLP-1 Agonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global GLP-1 Agonist Consumption Value Market Share by Type in 2022
Figure 4. Long-Acting Drug Examples
Figure 5. Short-Acting Drug Examples
Figure 6. Global GLP-1 Agonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global GLP-1 Agonist Consumption Value Market Share by Application in 2022
Figure 8. Diabetes Examples
Figure 9. Obesity Examples
Figure 10. Nonalcoholic Fatty Liver Disease Examples
Figure 11. Metabolic Disorder Examples
Figure 12. Alzheimer's Disease Examples
Figure 13. Other Examples
Figure 14. Global GLP-1 Agonist Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global GLP-1 Agonist Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global GLP-1 Agonist Sales Quantity (2018-2029) & (K Units)
Figure 17. Global GLP-1 Agonist Average Price (2018-2029) & (US$/Unit)
Figure 18. Global GLP-1 Agonist Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global GLP-1 Agonist Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of GLP-1 Agonist by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 GLP-1 Agonist Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 GLP-1 Agonist Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global GLP-1 Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global GLP-1 Agonist Consumption Value Market Share by Region (2018-2029)
Figure 25. North America GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 28. South America GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa GLP-1 Agonist Consumption Value (2018-2029) & (USD Million)
Figure 30. Global GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global GLP-1 Agonist Consumption Value Market Share by Type (2018-2029)
Figure 32. Global GLP-1 Agonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global GLP-1 Agonist Consumption Value Market Share by Application (2018-2029)
Figure 35. Global GLP-1 Agonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America GLP-1 Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America GLP-1 Agonist Consumption Value Market Share by Country (2018-2029)
Figure 40. United States GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe GLP-1 Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe GLP-1 Agonist Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific GLP-1 Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific GLP-1 Agonist Consumption Value Market Share by Region (2018-2029)
Figure 56. China GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America GLP-1 Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America GLP-1 Agonist Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa GLP-1 Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa GLP-1 Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa GLP-1 Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa GLP-1 Agonist Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa GLP-1 Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. GLP-1 Agonist Market Drivers
Figure 77. GLP-1 Agonist Market Restraints
Figure 78. GLP-1 Agonist Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of GLP-1 Agonist in 2022
Figure 81. Manufacturing Process Analysis of GLP-1 Agonist
Figure 82. GLP-1 Agonist Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
